Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.

Authors

Andrew Armstrong

Andrew J. Armstrong

Duke Cancer Institute, Duke University, Durham, NC

Andrew J. Armstrong , Santosh Gupta , Patrick Healy , Gabor Kemeny , Lauren Beth Leith , Michael Zalutsky , Charles Spritzer , Catrin Davies , Katie Ware , Jason Somarelli , Kris Wood , Wayne Glover , Shiaowen David Hsu , Drew Gerber , Colin Rothwell , Kelly Mundy , Monika Anand , Simon Gregory , Susan Halabi , Daniel J. George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02204943

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 160)

DOI

10.1200/JCO.2018.36.6_suppl.160

Abstract #

160

Poster Bd #

A2

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.

Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.

First Author: Asli Munzur

First Author: Aishwarya Subramanian